Virinostat (SAHA), another hydroxamic acid HDACi, inhibits STAT3 and also STAT1 phosphorylation, and was shown to attenuate GVHD and inhibit proinflammatory cytokine production during the initiation phase of GVHD (173). This evidence concerns the gene STAT3 and graft versus host disease.